Jinyao Pharmaceutical Co., Ltd.
-
Founded in:
1999-12-01 -
Country:
China -
Address:
No. 19, Xinye 9th Street, West District, Tianjin Development Zone -
Tax NO.:
9112000071824811X4 -
Registered Funds:
1,091.88668 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| DL-Methionine |
Extract from the above information
More
Extract from the above information |
59-51-8 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Glycine |
Unspecified
More
Unspecified |
56-40-6 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Flunarizine dihydrochloride |
Extract from the above information
More
Extract from the above information |
30484-77-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dexamethasone-17-acetate |
Extract from the above information
More
Extract from the above information |
1177-87-3 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1-Benzhydryl-4-(3-phenyl-ethyl-propenyl)-piperazine |
This product is a piperazine calcium channel antagonist that can block calcium influx into vascular smooth muscle, causing vasodilation and improving cerebral and coronary circulation, especially having a certain selective effect on cerebral blood vessels. This product can inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the intracellular cAMP concentration, inhibiting the release of histamine, 5-hydroxytryptamine, bradykinin and other biologically active substances, and also inhibiting the activation of complement C4.
More
This product is a piperazine calcium channel antagonist that can block calcium influx into vascular smooth muscle, causing vasodilation and improving cerebral and coronary circulation, especially having a certain selective effect on cerebral blood vessels. This product can inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the intracellular cAMP concentration, inhibiting the release of histamine, 5-hydroxytryptamine, bradykinin and other biologically active substances, and also inhibiting the activation of complement C4. |
0 |